Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.16	49.88	42.21
Graham Fair Price	-61.75	5.13	13.42
PEG	-1357.92	-1.75	-0.12
Price/Book	16.03	2.71	2.33
Price/Cash Flow	2860.69	-1701.80	57.48
Prices/Earnings	647.39	149.48	20.00
Price/Sales	22.08	6.16	5.05
Price/FCF	2860.69	-1701.80	57.48
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.95	0.38	0.38
Operating Margin	9.14	0.09	0.08
ROA	-84.63	< 0.005	< 0.005
ROE	0.03	< 0.005	-84.47
ROIC	< 0.005	< 0.005	14.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.15	91.09
Dividends QOQ	0.00	< 0.005	-100.00
EBIT QOQ	7.45	< 0.005	-99.88
EPS QOQ	1.67	-0.85	-48.74
FCF QOQ	0.79	-1.04	32.19
Revenue QOQ	0.05	-0.08	57.99
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	105.33	119.84	13.78
Days Sales Outstanding (DSO)	63.54	64.49	1.49
Inventory Turnover	0.85	0.75	-12.11
Debt/Capitalization	0.63	0.63	-0.66
Quick Ratio	0.91	0.88	-3.63
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.57	16.09	-2.92
Cash	6.30	5.96	-5.45
Capex	-0.37	-0.35	7.55
Free Cash Flow	0.67	-0.03	-96.20
Revenue	7.66	7.07	-7.72
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.48	1.48	0.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.32	16.71	9.04
Naive Interpretation	Member

06 - Financial Health · Weak

Rating